(2S,3S,4S,5R)-2,3,4,5-Tetrahydroxy-6-oxohexanoic acid, 95.0%, 5g

3,5-Dimethylcyclohexane-1-carboxylic acid, 98%, 250mg

Fmoc-(S)-3-Amino-4-(1-naphthyl)-butyric acid, 97%, 1g

2-Hydroxy-3,5-diiodobenzoic acid, 95.0%, 500g

(2E)-1-(4-bromophenyl)-3-(2-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

6-Amino-3-bromo-2-methylpyridine>98.0%(GC)(T)5g

(2R,4R)-tert-butyl 4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate, 97%, 100mg

FMOC-L-BETA-HOMOVALINE, 99.0%, 100mg

6-Methyl-7-nitro-1H-indazole, 95.0%, 1g

1-Ethyl-1H-pyrazole-5-carboxylic acid, 95.0%, 10g

(S)-METHYL 4,5,6,7-TETRAHYDRO-3H-IMIDAZO[4,5-C]PYRIDINE-6-CARBOXYLATE 2HCL, 95.0%, 250mg

1-BOC-4-(2-PYRIDINYLCARBONYL)-PIPERAZINE, 95.0%, 250mg

2-(1-methyl-1H-benzimidazol-2-yl)ethanol dihydrate, 95.0%, 25g